BS
PCRX icon

Banco Santander’s Pacira BioSciences PCRX Stock Holding History

Banco Santander’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.75M Buy
166,000
+10,000
+6% +$222K 0.03% 220
2025
Q4 		$4.04M Buy
156,000
+3,000
+2% +$71.3K 0.03% 214
2025
Q3 		$3.94M Buy
153,000
+17,000
+13% +$418K 0.04% 220
2025
Q2 		$3.25M Sell
136,000
-6,000
-4% -$151K 0.03% 230
2025
Q1 		$3.53M Buy
142,000
+15,100
+12% +$362K 0.04% 220
2024
Q4 		$2.39M Buy
126,900
+6,900
+6% +$121K 0.03% 226
2024
Q3 		$1.81M Sell
120,000
-18,373
-13% -$314K 0.02% 240
2024
Q2 		$3.96M Buy
+138,373
New +$3.94M 0.05% 191

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return